The Complex Roadmap to Infectious Disease Innovation: The Intersection of Bugs, Drugs, and Special Populations
- PMID: 33769563
- DOI: 10.1002/cpt.2208
The Complex Roadmap to Infectious Disease Innovation: The Intersection of Bugs, Drugs, and Special Populations
Comment on
-
Pharmacology of HIV Cure: Site of Action.Clin Pharmacol Ther. 2021 Apr;109(4):841-855. doi: 10.1002/cpt.2187. Epub 2021 Mar 5. Clin Pharmacol Ther. 2021. PMID: 33540481 Free PMC article. Review.
References
-
- Franklin, J.M., Lin, K.J., Gatto, N.M., Rassen, J.A., Glynn, R.J. & Schneeweiss, S. Real-world evidence for assessing pharmaceutical treatments in the context of COVID-19. Clin. Pharmacol. Ther. 109, 818-828 (2021).
-
- Choi, S.-Y., Arya, V. & Reynolds, K. Clinical pharmacology-informed development of COVID-19 therapeutics: Regulatory experience. Clin. Pharmacol. Ther. 109, 810-812 (2021).
-
- Aliu, P., Sarp, S. & Fitzsimmons, P. Increasing use of compassionate use/managed access channels to obtain medicines for use in COVID-19. Clin. Pharmacol. Ther. (2021). https://doi.org/10.1002/cpt.2140
-
- Perelson, A.S. & Ke, R. Mechanistic modelling of SARS-CoV-2 and other infectious diseases and the effects of therapeutics. Clin. Pharmacol. Ther. 109, 829-840 (2021).
-
- Devanathan, A.S. & Cottrell, M.L. Pharmacology of HIV cure: site of action. Clin. Pharmacol. Ther. 109, 841-855 (2021).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
